Vanderbilt-Ingram Cancer Center
Mesothelioma Care at Vanderbilt-Ingram Cancer Center
The Vanderbilt-Ingram Cancer Center is at the forefront of lung cancer and mesothelioma treatment, providing screenings, second opinions and individualized treatment for a patient’s cancer.
Specialists at the Vanderbilt-Ingram Cancer Center have experience diagnosing the disease, as well as providing second opinions, with a variety of tests like CT scans, MRIs and endoscopic ultrasounds. The center provides a variety of treatment options depending on the patient’s individual case, including advanced robotic surgery, minimally invasive surgery, immunotherapy, radiation and chemotherapy. Radiation is used as a treatment or as a palliative therapy to reduce symptoms and manage pain. The center offers targeted therapy, biologic therapy and clinical trials to patients as alternative treatment options, as well. They assess the cancer on an individual basis, using genetic testing to find the best treatment options.
Patient navigators are also available to patients to relieve them of the stress of scheduling appointments and collecting medical and financial records. Patients may access survivorship and support services as part of their care at the Vanderbilt-Ingram Cancer Center.
Vanderbilt-Ingram Cancer Center Specializations
- Chemotherapy
- Radiation therapy
- Surgery
- Targeted therapy
Vanderbilt-Ingram Cancer Center Accreditations
- CEO Cancer Gold Standard
- National Cancer Institute (NCI) Comprehensive Care Center
- National Cancer Institute (NCI) National Clinical Trials Network accreditation
- National Comprehensive Cancer Network (NCCN) accreditation
Mesothelioma Clinical Trials at Vanderbilt-Ingram Cancer Center
Clinical trials can provide eligible mesothelioma patients with additional choices for their treatment. Information about whether trials may be available at Vanderbilt-Ingram Cancer Center can be found below:
Conditions: Mesothelioma
Last Updated: 5/19/2026
Status: Recruiting
Conditions: Mesothelioma
Last Updated: 4/30/2026
Status: Recruiting
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Conditions: Mesothelioma
Last Updated: 12/5/2025
Status: Recruiting
Conditions: Mesothelioma
Last Updated: 4/17/2026
Status: Active, not recruiting
Sources
Vanderbilt-Ingram Cancer Center. Lung Cancer.
Vanderbilt-Ingram Cancer Center. Malignant Mesothelioma Treatment.